Search

You searched for "requirements"

1365 results found

Intravitreal dexamethasone implant for recurrent CMO secondary to IGS

1 February 2017 | | EYE - Vitreo-Retinal
In this prospective study the authors present the data obtained on the efficacy and safety of the dexamethasone implant (0.7 mg) in the treatment of recurrent cystoid macular oedema (PCME) due to Irvine–Gass syndrome in patients with uncomplicated pseudophakia (off-label...

RCOphth 2023 Preview

15 May 2023 | RCOphth2023, preview, eye news, iccbirmingham
Here is our rundown of the RCOphth 2023 Annual Congress before it all kicks off, with dates for your diary, competitions, interviews and more!

Falkirk girl with sight loss is World Book Day winner

2 May 2024 | RNIB, Scotland, Charity, sight loss, awareness, competition, braille, see differently, creativity, school
Grace Kidd, 9, from Falkirk, is the winner of a creative writing competition hosted for the first time by leading sight loss charity, RNIB, to mark World Book Day.

International Women’s Day 2025: In Conversation With Dr Michelle Le Cheminant

9 March 2025 | international womans day, conversation, Q&A, ophthalmology, gender
Women make up 70% of the global health and social workforce but hold only 25% of leadership roles. In ophthalmology, women represent just 25-30% of ophthalmologists. Research shows that hospitals with increased female surgeons and anesthetists have lower odds of...

The results of the last survey Oct22

3 October 2022 | | EYE - General
I thank everyone for their time in responding to this edition’s survey questions. The first question relates to an issue I have previously discussed around consent for second eye cataract surgery. I touch on this point again for two reasons....

Does a gut-eye axis exist?

1 October 2019 | | EYE - General
Simerdip Kaur takes a look at the latest ophthalmology-related news stories and asks which are based on facts and which are ‘fake news’. Headline: Does a gut-eye axis exist? Over a decade ago, the Human Microbiome Project was launched by...

Macula re-attachment following intravitreal ranibizumab in rhegmatogenous retinal detachment

1 February 2015 | | EYE - Vitreo-Retinal, EYE - General
Ranibizumab (Lucentis) is a vascular endothelial growth factor inhibitor (anti-VEGF) used for treatment of choroidal neovascular membrane [1]. We report a case where macula off inferior rhegmatogenous retinal detachment was misdiagnosed as wet age-related macular degeneration (AMD) and three intravitreal...

A step-by-step approach to the diagnosis and management of Sands of Sahara Syndrome

1 October 2018 | | EYE - Cornea, EYE - Cataract, EYE - Refractive, EYE - General
Sands of Sahara syndrome (diffuse lamellar keratitis) is a rare postoperative complication of Laser in situ keratomileusis (LASIK). Its estimated prevalence is reported to be 2-4% among LASIK cases [1], despite that, it is more likely to be encountered by...

Oculogyric crisis with B12 deficiency

1 June 2022 | | EYE - Neuro-ophthalmology, EYE - Imaging, EYE - General
An oculogyric crisis (OGC) is a dystonic movement disorder of the eyes which can last from seconds to hours. Although there is no published diagnostic criteria for OGC, typically the onset is acute, and it is characterised by conjugate upward...

Presumed DALK stromal graft rejection following Covid-19 infection

4 December 2024 | | EYE - Cornea
Case report A 45-year-old healthy male patient with a past ocular history of keratoconus and right deep-anterior lamellar keratoplasty (DALK) graft performed 10 months prior, presented to our eye casualty clinic with a two-day history of right photophobia and epiphora....

DMEK vs. UT-DSAEK: has the debate been finally concluded?

1 October 2021 | | EYE - Cornea, EYE - General
In recent years the surgical treatment of corneal endothelial dystrophy has progressed tremendously. Descemet’s membrane endothelial keratoplasty (DMEK) is the newest iteration in the line of rapid surgical advances that has taken place. However, the previously accepted gold standard prior...

My Top Five: Promising gene therapies for ocular conditions

4 December 2024 | | EYE - Vitreo-Retinal
Gene therapy, a pivotal advancement in modern medicine, particularly shines in ophthalmology. By targeting defective genes with engineered vectors, this approach promises significant strides in treating inherited retinal diseases. This article reviews the top five gene therapies in late-stage trials,...